These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7535452)

  • 61. Cryopreservation, cytokine mobilization, and autotransplantation of peripheral blood stem cells.
    Harada M; Taniguchi S; Teshima T; Makino S; Takamatsu Y; Akashi K; Gondo H; Etoh T; Kondo S; Shibuya T
    Prog Clin Biol Res; 1992; 377():297-308. PubMed ID: 1279707
    [No Abstract]   [Full Text] [Related]  

  • 62. [Stem cell-colony stimulating factors].
    Urabe A; Kobayashi Y; Takaku F
    Gan No Rinsho; 1989 May; Spec No():287-93. PubMed ID: 2481048
    [No Abstract]   [Full Text] [Related]  

  • 63. Mobilization of peripheral stem cells for transplantation.
    Nemunaitis J; Rosenfeld C
    J Hematother; 1993; 2(3):351-5. PubMed ID: 7921995
    [No Abstract]   [Full Text] [Related]  

  • 64. The use of hematopoietic growth factors for high-dose chemotherapy and peripheral blood progenitor cell transplantation.
    Kanz L; Brugger W; Mertelsmann R
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):10-8. PubMed ID: 7528446
    [No Abstract]   [Full Text] [Related]  

  • 65. Growth factors promote high-dose chemotherapy.
    Randall T
    JAMA; 1991 Dec; 266(21):2949-50. PubMed ID: 1726474
    [No Abstract]   [Full Text] [Related]  

  • 66. [Role of marrow purging].
    Rizzoli V; Carlo-Stella C; Mangoni L
    Haematologica; 1991 Jun; 76 Suppl 3():311-20. PubMed ID: 1684346
    [No Abstract]   [Full Text] [Related]  

  • 67. [Clinical administration of hematopoietic growth factors. When and where?].
    Ottmann OG; Seipelt G; Hoelzer D
    Internist (Berl); 1997 Dec; 38(12):1160-7. PubMed ID: 9465321
    [No Abstract]   [Full Text] [Related]  

  • 68. The role of autologous stem cell reconstitution in intensive therapy for resistant neoplasms.
    Deisseroth A; Abrams RA
    Cancer Treat Rep; 1979 Mar; 63(3):461-71. PubMed ID: 371800
    [No Abstract]   [Full Text] [Related]  

  • 69. High dose cytotoxic chemotherapy with peripheral blood stem cell (PBPC) transplantation--malignancy and beyond.
    Siddiqui T
    J Pak Med Assoc; 1997 Nov; 47(11):266-7. PubMed ID: 9510627
    [No Abstract]   [Full Text] [Related]  

  • 70. Biological and clinical aspects of hematopoietic stem cells.
    Spangrude GJ
    Annu Rev Med; 1994; 45():93-104. PubMed ID: 7515222
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The blood bank as a source of hematopoietic stem cells.
    Lasky LC
    Prog Clin Biol Res; 1986; 211():199-225. PubMed ID: 3515360
    [No Abstract]   [Full Text] [Related]  

  • 72. Peripheral blood mobilization of hematopoietic stem cells: cytokine-mediated regulation of adhesive interactions within the hematopoietic microenvironment.
    Santucci MA; Lemoli RM; Tura S
    Acta Haematol; 1997; 97(1-2):90-6. PubMed ID: 8980614
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Peripheral blood stem cell collections for autologous transplantation using the CS-3000 blood cell separator.
    Hogge DE; Bernardino L; Benny WB; Barnett M
    Prog Clin Biol Res; 1990; 337():71-3. PubMed ID: 1972286
    [No Abstract]   [Full Text] [Related]  

  • 74. Approaches to blood stem cell mobilisation. Initial Australian clinical results.
    Juttner CA; To LB; Haylock DN; Dyson PG; Bradstock KF; Dale BM; Enno A; Sage RE; Szer J; Toogood IR
    Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():22-4. PubMed ID: 1969302
    [No Abstract]   [Full Text] [Related]  

  • 75. Flow cytometric analysis of peripheral blood stem cells.
    Bender JG; Unverzagt K
    J Hematother; 1993; 2(3):421-30. PubMed ID: 7522893
    [No Abstract]   [Full Text] [Related]  

  • 76. [Autologous bone marrow grafts and solid tumors].
    Beaulieu R
    Union Med Can; 1983 May; 112(5):450-2, 460. PubMed ID: 6349082
    [No Abstract]   [Full Text] [Related]  

  • 77. The potential for the use of colony-stimulating factors in autologous bone marrow transplantation.
    Peters WP
    Recent Results Cancer Res; 1991; 121():182-8. PubMed ID: 1713337
    [No Abstract]   [Full Text] [Related]  

  • 78. Peripheral blood stem cell transplantation: historical perspective, current status, and prospects for the future.
    Inwards D; Kessinger A
    Transfus Med Rev; 1992 Jul; 6(3):183-90. PubMed ID: 1353998
    [No Abstract]   [Full Text] [Related]  

  • 79. Allogeneic marrow reconstitution using peripheral blood stem cells: the dawn of a new era.
    Lane TA
    Transfusion; 1996 Jul; 36(7):585-9. PubMed ID: 8701452
    [No Abstract]   [Full Text] [Related]  

  • 80. The biology and clinical uses of blood stem cells.
    To LB; Haylock DN; Simmons PJ; Juttner CA
    Blood; 1997 Apr; 89(7):2233-58. PubMed ID: 9116266
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.